Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-08-000016
Filing Date
2008-02-15
Accepted
2008-02-15 10:31:29
Documents
1
Period of Report
2008-02-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3003
  Complete submission text file 0000875320-08-000016.txt   4650
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HOLOGIE INC 35 CROSBY DRIVE BEDFORD MA 01730
Business Address
ULLIAN ELAINE (Reporting) CIK: 0001190290 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 08621354